文献速递主动脉疾病

英国多中心研究:GORE TAG胸主动脉分支覆膜支架治疗主动脉弓邻近病变的早期经验

The United Kingdom Branch Endoprosthesis for Aortic arch Treatment study: Early experience with the GORE TAG thoracic branch endoprosthesis.
PubMed 文献 · J Vasc Surg · 2026-07-06

该研究为英国13家血管中心的多中心回顾性队列研究,纳入2024年1月至2025年9月连续70例使用GORE TAG胸主动脉分支覆膜支架(TBE)治疗主动脉弓邻近病变的患者。

要点

  • 卒中发生率4.3%,脊髓缺血1.4%,无截瘫病例。
  • 随访影像中靶血管及分支通畅率100%,再干预率8.6%。

核心结论

  • 在英国多中心真实世界人群中,GORE TAG TBE治疗主动脉弓邻近病变技术成功率高、早期结果可接受。
  • 结果支持TBE作为复杂弓邻近病变的实用腔内选择。

研究设计与样本

  • 多中心回顾性队列研究,覆盖英国13家血管中心。
  • 连续纳入2024年1月至2025年9月使用GORE TAG TBE治疗弓邻近胸主动脉病变的患者70例。
  • 纳入指征包括退行性动脉瘤、急慢性B型夹层、穿透性主动脉溃疡、壁内血肿及创伤后假性动脉瘤,含择期与非择期手术。

主要发现

  • 平均年龄65岁,男性占62.9%。
  • 45.7%(32/70)手术为紧急或非择期。
  • 近端锚定区位于2区者占88.6%(62/70),其余位于0区和1区。
  • 卒中4.3%(3/70),脊髓缺血1.4%(1/70),无截瘫病例;随访影像靶血管及分支通畅率100%(67/67),再干预8.6%,仅1例(1.4%)为器械相关再干预。

临床怎么用

  • 对于近端锚定需覆盖弓上分支的弓邻近胸主动脉病变,可考虑使用GORE TAG TBE进行腔内修复。
  • 需关注卒中与脊髓缺血风险,术后应进行影像随访评估靶血管及分支通畅性。

局限性

  • 回顾性研究设计。
  • 样本量70例,随访时间有限。
  • 早期结果,需更长期随访验证耐久性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Thoracic endovascular aortic repair is established for descending thoracic aortic pathology but becomes more complex when proximal sealing requires coverage of supra-aortic branches. Off-the-shelf thoracic branch endografts have expanded endovascular options for arch-adjacent disease; however, real-world multicenter data remains limited. This study reports early outcomes of thoracic branch endograft repair for arch-adjacent thoracic aortic pathology in routine UK practice. METHODS: This is a retrospective multicenter cohort study conducted across 13 UK vascular centers. All consecutive patients undergoing endovascular repair of arch-adjacent thoracic aortic pathology using the GORE TAG Thoracic Branch Endoprosthesis (TBE; W. L. Gore & Associates) between January 2024 and September 2025 were included. Indications included degenerative aneurysm, acute and chronic type B dissection, penetrating aortic ulcer, intramural hematoma, and post-traumatic pseudoaneurysm. Both elective and nonelective procedures were analyzed. Primary outcomes included technical success and early clinical outcomes. Secondary outcomes included neurological complications, reintervention, endoleak profile, target vessel, and branch patency. RESULTS: Seventy patients were included. Mean age was 65 years, and 62.9% patients were males. Nearly half of procedures were performed urgently or in a nonelective setting 45.7% (32/70). Proximal sealing was achieved in zone 2 in 88.6% of cases (62/70), with the remainder in zones 0 and 1. Technical success was achieved in 65/70 patients (92.9%). Thirty-day mortality was 2.9% (2/70). Stroke occurred in 4.3% of patients (3/70), and spinal cord ischemia occurred in 1.4% (1/70), with no cases of paraplegia. Target vessel and branch patency were achieved in all cases who had follow-up imaging 100% (67/67). Reintervention was required in 8.6% of patients with only one case requiring a device-related reintervention (1.4%). CONCLUSIONS: In this multicenter UK experience, thoracic branch endograft repair for arch-adjacent thoracic aortic pathology was associated with high technical success and acceptable early outcomes in a heterogeneous real-world population. These findings support the use of thoracic branch endografting with Gore TBE as a pragmatic endovascular option for complex arch-adjacent disease.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Hamo N, Morshed A, Mastracci TM, et al. The United Kingdom Branch Endoprosthesis for Aortic arch Treatment study: Early experience with the GORE TAG thoracic branch endoprosthesis. J Vasc Surg. 2026. PMID: 42409249. doi:10.1016/j.jvs.2026.06.156

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。